Stocks TelegraphStocks Telegraph
Stock Ideas

AXSM Stock Performance and Key Statistics

NASDAQ : AXSM

Axsome Therapeutics

$223.70
17.17+8.31%
At Close 4:00 PM
58.16
BESG ScoreESG Rating

stock performance chart

AXSM Fundamental Analysis

Based on recent data, Axsome Therapeutics, Inc. (AXSM) shows an Average True Range (ATR) of 6.18 and an Enterprise Value of 3.17B. Its average trading volume over the past 3 months is 678.03K, indicating liquidity. These fundamental metrics provide insight into AXSM's underlying financial health and market activity.

ATR6.18
Enterprise Value3.17B
Avg Vol (3 Months)678.03K
Avg Vol (10 Days)1.65M

AXSM Technical Analysis Indicators

Axsome Therapeutics, Inc. (AXSM) technical indicators as of May 5, 2026: the SMA 20 is -9.83%, SMA 50 at -5.89%, and SMA 200 at 22.82%. The RSI 14 value is 31.9, suggesting its current momentum. These technical analysis signals help assess AXSM's price trends and potential future movements.

SMA 20-9.83%
SMA 50-5.89%
SMA 20022.82%
RSI 1431.9

AXSM Stock Performance Overview

Axsome Therapeutics, Inc. (AXSM) stock performance overview as of May 5, 2026: The 52-week high is $234.29 (currently -14.78% below), and the 52-week low is $96.09 (currently 87.6% above). Over the past year, AXSM's performance is 96.93%, compared to the S&P 500's 16.14% change.

52-Week High234.29
52-Week High Chg-14.78%
52-Week Low96.09
52-Week Low Chg+87.60%
S&P 500 52-Week Chg16.14%

Axsome Therapeutics, Inc. (AXSM) Historical Stock Performance

According to market data, Axsome Therapeutics, Inc. (AXSM) stock's recent performance metrics show that over the last month, AXSM is 24.66%, with a Year-to-Date (YTD) performance of 1.02%. Over the past year, the stock has seen a 96.93% change. These figures summarize AXSM's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
High234.29234.29234.29234.29234.29234.29
Low180159.92152.28123.596.09152.28
Performance+4.34%+24.66%+44.21%+68.22%+96.93%+1.02%

Industry Analysis and Valuation

According to current financial data, AXSM stock's P/E (TTM) ratio is -63.20, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for AXSM, including P/S (18.32), P/B (212.07), and P/FCF (-124.57), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationAXSMSector MedianIndustry AvgS&P 500
P/E (TTM)-63.2-1.22-5.1232.59
P/S (TTM)18.323.69464.325.98
P/B (TTM)212.070.28293.84.61
P/FCF (TTM)-124.57-1.48-445.4931.99

Frequently Asked Questions

How is AXSM price-to-earnings ratio currently?
AXSM has a current P/E ratio of -63.2
How are AXSM's price-to-sale and price-to-book ratios?
The AXSM stock has a trailing twelve month price-to sales (P/S) ratio of 18.32 while its price-to-book (P/B) value is 212.07.
Is Axsome Therapeutics, Inc.'s price-to-cashflow ratio high or low?
AXSM's price-to-free-cashflow (P/FCF) ratio is -124.57, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for AXSM?
Based on AXSM's recent bid, its distance from 20 days simple moving average is -9.83%. It is -5.89% apart from 50 days simple moving average, and it is 22.82% apart from 200 days simple moving average.
What is the 52-week price range for AXSM?
The 52-week high for AXSM is $234.29 which is -14.78% away from the current price level whereas the distance of that from the 52-week low of $96.09 stands at 87.6%.
An overview of AXSM's stock performance: how did it fare?
The performance of AXSM stock was not encouraging with most of its significant price indicators in green. Axsome Therapeutics, Inc.(NASDAQ: AXSM) shares have moved upward +8.31% or $17.17 in the latest trading session and have gained 1.02% year-to-date (YTD). The stock has gained nearly 96.93% over the past year. After moving 44.21% over the trailing 3-month period, the stock is 68.22% higher in the 6-month period. Looking at its performance over the shorter term, it'sgained 4.34% a week and 24.66% a month.
What is AXSM's 14-day relative strength index (RSI)?
The current 14-day RSI for AXSM stock is 31.9. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For AXSM, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Axsome Therapeutics, Inc. (AXSM) has a 14-day ATR of 6.18.
What is AXSM's current enterprise value?
After closing at $206.53 with 51.15M of its shares outstanding, the current enterprise value of AXSM is roughly 3.17B.
Over the past year, how has the stock price of AXSM changed?
Axsome Therapeutics, Inc. (NASDAQ: AXSM) is up 96.93% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 16.14%. AXSM stock price is also up 1.02% on its value in year-to-date trading.
What is the average trading volume for AXSM shares?
The number outstanding shares of AXSM is 51.15M, and of these 84.14% shares are freely available for trading. On average, AXSM stock has traded 1.65M shares per day for the past 10 days. A total of 2.5M shares changed hands during the last trading session with the average session volume of 652.2K shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph